Today: 4 July 2026
Browse Category

Dividends 16 December 2025 - 18 December 2025

Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

Banco BBVA Argentina (BBAR) Stock Surges on Dec. 18, 2025: Dividend Headlines, FX Overhaul Tailwinds, and Where Analysts See the Shares Next

New York / Buenos Aires — December 18, 2025. Banco BBVA Argentina S.A. shares are back in the spotlight today after a sharp move higher in U.S. trading. The bank’s NYSE-listed American Depositary Shares traded around $18.44, up roughly $1.48 on the session, with trading ranging from roughly $16.57 to $18.50. That kind of single-day swing is not unusual for Argentine financial stocks, which often behave like a “macro instrument” first and a bank second. But today’s move is landing on top of a stack of genuinely fresh, stock-specific developments: a new dividend installment disclosed in an SEC filing, the closing of a strategic auto-finance transaction, and major changes to Argentina’s currency framework that markets have broadly interpreted as credibility-positive.
18 December 2025
·
HSBC Holdings Plc Stock News Today (Dec. 18, 2025): Dividend Lands, Shares Hold Near Highs as Hang Seng Deal and Rate Cuts Shape the Outlook

HSBC Holdings Plc Stock News Today (Dec. 18, 2025): Dividend Lands, Shares Hold Near Highs as Hang Seng Deal and Rate Cuts Shape the Outlook

HSBC Holdings Plc stock is starting Dec. 18 with two narratives colliding in a very “2025 markets” way: cash coming back to shareholders today via a dividend payment, and a forward-looking debate over what happens next as central banks edge toward lower rates and HSBC pursues a major Hong Kong restructuring move. On the screen, HSBC looks steady and strong. Under the hood, investors are weighing a temporary buyback pause tied to the planned Hang Seng Bank take-private, a push into productivity tools like generative AI, and a set of legal and macro risks that will matter much more once the “dividend day dopamine” wears off.
18 December 2025
····
Singtel Stock (SGX: Z74) News on 18 Dec 2025: Optus Outage Review, Dividend Support, Buyback Momentum, and Analyst Price Targets

Singtel Stock (SGX: Z74) News on 18 Dec 2025: Optus Outage Review, Dividend Support, Buyback Momentum, and Analyst Price Targets

Singapore Telecommunications Limited is back in the market spotlight on 18 December 2025, as investors weigh a fresh round of negative headlines around its Australian unit Optus against a steadier core financial picture: rising underlying profit, a bigger interim dividend, ongoing share buybacks, and continued asset-recycling moves that have strengthened the balance sheet. Singtel shares were recently indicated around S$4.52 with a previous close around S$4.55, and a day range near S$4.52 to S$4.61. Investing.com+1
18 December 2025
··
ANZ Group Holdings Limited (ASX: ANZ) Stock: AGM Second Strike, CEO Bonus Waiver, Dividend Outlook and Analyst Forecasts (18 December 2025)

ANZ Group Holdings Limited (ASX: ANZ) Stock: AGM Second Strike, CEO Bonus Waiver, Dividend Outlook and Analyst Forecasts (18 December 2025)

SYDNEY — ANZ Group Holdings Limited shares were steady on Thursday after shareholders delivered a second consecutive “strike” against the bank’s remuneration report at its 2025 annual general meeting — a governance flashpoint that can escalate into a board spill process under Australia’s rules. The immediate market response was muted, with Reuters reporting the stock trading around A$36.13 after early volatility. Reuters But don’t confuse “muted price action” with “no consequences.” ANZ’s AGM put three things on loudspeaker for investors assessing the ANZ share price into 2026:
18 December 2025
··
Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Stock (ZTS) News Today: $1.75B Convertible Notes, Accelerated Buybacks, Dividend Raise, and Analyst Forecasts (Dec. 17, 2025)

Zoetis Inc. stock is back in focus on Wednesday, December 17, 2025, as investors weigh a fresh analyst update against a flurry of recent corporate actions—most notably a $1.75 billion convertible notes financing designed to fund substantial share repurchases, plus a dividend increase heading into 2026. MarketScreener+2investor.zoetis.com+2 Zoetis is the world’s largest pure-play animal health company, with a portfolio spanning companion animal and livestock medicines, vaccines, diagnostics, and technology. Business Wire+1
17 December 2025
··
Ambev (ABEV) Stock News Today: Dividend Boost, New Capacity, and 2026 Forecasts in Focus (Dec. 17, 2025)

Ambev (ABEV) Stock News Today: Dividend Boost, New Capacity, and 2026 Forecasts in Focus (Dec. 17, 2025)

As of Wednesday, December 17, 2025, Ambev S.A. is back in the spotlight for a very “Brazil-meets-Wall-Street” reason: a fresh round of shareholder payouts colliding with a steady drumbeat of operational investments aimed at defending its premium beer footprint. With the ADR trading around $2.55 in the latest available quote, investors are weighing three storylines at once: cash returns, capacity expansion tied to premiumization, and a forecast picture that ranges from “meh/hold” to “quietly bullish.”
17 December 2025
···
Diageo Shares Jump on $2.3bn Asahi Deal: What Today’s Kenya Exit Means for a Turnaround, Dividends and the £16 “Value” Debate

Diageo Shares Jump on $2.3bn Asahi Deal: What Today’s Kenya Exit Means for a Turnaround, Dividends and the £16 “Value” Debate

Diageo is back in focus on 17 December 2025 after agreeing to sell its 65% stake in East African Breweries to Asahi for $2.3bn. Here’s what the deal means for debt, dividends, and whether the share-price slump since 2022 is finally setting up a recovery. Investegate+2Reuters+2 London-listed drinks giant Diageo—the owner of Johnnie Walker and Guinness—has delivered one of its biggest corporate headlines of 2025, agreeing to sell its controlling stake in East African Breweries to Japan’s Asahi Group in a transaction expected to generate estimated net proceeds of $2.3 billion after tax and transaction costs. Investegate+1
17 December 2025
····
HSBC Holdings Plc Stock News Today (Dec 17, 2025): Hang Seng Buyout Timeline, Analyst Targets, Dividend Watch and Key Risks

HSBC Holdings Plc Stock News Today (Dec 17, 2025): Hang Seng Buyout Timeline, Analyst Targets, Dividend Watch and Key Risks

HSBC Holdings Plc stock is back in the spotlight on 17 December 2025, with investors weighing near-term price action against a much bigger strategic catalyst: HSBC’s plan to privatise Hang Seng Bank in Hong Kong. Add in fresh analyst calls, dividend expectations, and lingering regulatory headlines, and you’ve got a classic “global bank” mix of opportunity, risk, and spreadsheets hiding in the shadows. Here’s what matters right now for HSBC Holdings Plc, and what to watch next.
17 December 2025
··
BP PLC Stock News Today (December 17, 2025): Oil Volatility, Buybacks, Dividend Ahead, and the Lightsource bp Solar Deal

BP PLC Stock News Today (December 17, 2025): Oil Volatility, Buybacks, Dividend Ahead, and the Lightsource bp Solar Deal

December 17, 2025 — BP PLC stock is trading in the crosswinds of a sharply volatile oil market, while the company continues returning cash via buybacks and prepares to pay its next dividend. In the last 24 hours, energy-sector sentiment has been whipsawed by headlines on geopolitics and supply expectations, while BP-specific developments—from a solar joint venture move in Brazil to daily share repurchases—are shaping the near-term narrative for BP shares. Investegate+4Reuters+4London South East+4 Below is what’s moving BP PLC right now, plus the latest analyst forecasts and the key dates investors are watching into early 2026.
17 December 2025
·····
Singapore Airlines Ltd Stock (SGX: C6L) on 17 Dec 2025: Passenger Traffic Update, Dividend Dates, Analyst Targets, and What Matters Next

Singapore Airlines Ltd Stock (SGX: C6L) on 17 Dec 2025: Passenger Traffic Update, Dividend Dates, Analyst Targets, and What Matters Next

SINGAPORE — Singapore Airlines Limited shares were hovering around S$6.27 on Wednesday, down about 0.48%, as investors digested a fresh set of operational data pointing to steady travel demand — while keeping one eye on lingering profit headwinds tied to competition, costs, and the airline’s exposure to Air India. MarketScreener That tension is basically the SIA stock story right now: the planes are full, the network is busy, and demand is resilient — but the market is still debating how durable margins will be as yields soften and cost pressure refuses to retire politely.
17 December 2025
··
DBS Group Holdings Ltd Stock (SGX: D05): Latest News, Share Price, Dividend Outlook, and Analyst Forecasts as of 17 Dec 2025

DBS Group Holdings Ltd Stock (SGX: D05): Latest News, Share Price, Dividend Outlook, and Analyst Forecasts as of 17 Dec 2025

DBS Group Holdings Ltd—Southeast Asia’s largest lender by assets—heads into the last stretch of 2025 with investors weighing a rare mix of “boring bank” fundamentals and very 2025 catalysts. Reuters On 17 December 2025, DBS shares closed at S$55.05, after a recent run that put the stock near its 52-week highs. Investing.com+1
17 December 2025
··
Amphenol Stock (NYSE: APH) on December 16, 2025: Dividend Date, AI Rotation Shock, and Fresh Wall Street Forecasts

Amphenol Stock (NYSE: APH) on December 16, 2025: Dividend Date, AI Rotation Shock, and Fresh Wall Street Forecasts

Amphenol Corporation is back in the spotlight on Tuesday, December 16, 2025, as investors weigh a mix of near-term volatility, an important dividend timing milestone, and a longer-term growth story tied to data centers, defense, and high-speed interconnect demand. After a sharp sector pullback late last week, Amphenol stock is trading around the $129 level in afternoon U.S. trading on Dec. 16, reflecting a market that is simultaneously impressed by the company’s growth and cautious about valuation across “AI-adjacent” hardware and electronics names. StockAnalysis+2MarketBeat+2
16 December 2025
··
Noble Corporation (NE) Stock Slides on Dec. 16, 2025: Jackup Divestment, Analyst Downgrade, Dividend Yield and Black Sea Drilling Update

Noble Corporation (NE) Stock Slides on Dec. 16, 2025: Jackup Divestment, Analyst Downgrade, Dividend Yield and Black Sea Drilling Update

Noble Corporation plc is having a rough Tuesday. Shares of the offshore drilling contractor were trading around $27.85 in Tuesday afternoon action, down roughly 6% on the day after opening near $29.28 and swinging between about $27.67 and $29.73. StockAnalysis The pullback comes as investors juggle several cross-currents: a notable analyst downgrade tied to delayed ultra-deepwater contracting, Noble’s plan to sell six jackup rigs, a high dividend yield that keeps income-focused buyers interested, and fresh operational news tied to the company’s Globetrotter I drillship mobilization for a Black Sea exploration campaign.
16 December 2025
···
Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s, Inc. is having one of those “only-in-markets” weeks: the stock recently tagged fresh highs, investors chased a $30 special dividend, and now the share price is digesting both the rally and the dividend mechanics. As of Tuesday, Dec. 16, 2025, DDS was trading around $645.61, down roughly 4.9% on the day, after opening near $678 and swinging between about $629 and $688. StockAnalysis
16 December 2025
···
McDonald’s Stock (NYSE: MCD) on Dec. 16, 2025: Dividend Tailwinds, New Franchise Value Rules, and What Analysts Forecast Next

McDonald’s Stock (NYSE: MCD) on Dec. 16, 2025: Dividend Tailwinds, New Franchise Value Rules, and What Analysts Forecast Next

McDonald’s Corporation stock was under modest pressure in Tuesday’s session, even as investors digested fresh reporting on stricter “value” expectations for franchisees and the company’s latest dividend payout milestone. As of 19:02 UTC on Dec. 16, MCD traded around $315.20, down about 1.1% on the day, after opening near $319.11 and touching an intraday high of $320.31. For long-term shareholders, the story around McDonald’s stock right now is less about a single headline and more about a familiar set of drivers: traffic vs. pricing power, franchise alignment, value positioning in a stretched consumer backdrop, and capital returns—with analysts largely signaling that the stock’s near-term upside may be more incremental than explosive.
16 December 2025
···
Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Inc. is in focus on December 16, 2025, as investors weigh a fresh dividend raise, recent regulatory momentum, and a pipeline narrative that stretches from cardiovascular outcomes to the high-stakes obesity race. As of Dec. 16, 2025, Amgen shares traded around $324.36, slightly lower on the day, with an intraday range roughly between $323.05 and $326.03.
16 December 2025
··
Salesforce (CRM) Stock News Today (Dec. 16, 2025): Agentforce Updates, Dividend Spotlight, Analyst Targets, and What Investors Are Watching

Salesforce (CRM) Stock News Today (Dec. 16, 2025): Agentforce Updates, Dividend Spotlight, Analyst Targets, and What Investors Are Watching

Salesforce, Inc. stock is back in focus on Tuesday, December 16, 2025, as investors weigh a fresh round of “Agentforce” product ecosystem headlines against a still-evolving AI monetization story and Wall Street’s latest price targets. As of Dec. 16, 2025, Salesforce shares were trading around $252.94, down from the prior close of $254.58, with a day range of $252.59–$254.68 and a 52-week range of $221.96–$367.09, according to Investing.com’s live quote page. Investing.com
16 December 2025
···
Pfizer Forecasts Flat 2026 Sales and Lower Profit as COVID Demand Falls; PFE Dividend Remains $0.43

Pfizer Forecasts Flat 2026 Sales and Lower Profit as COVID Demand Falls; PFE Dividend Remains $0.43

Pfizer’s latest outlook is setting the tone for how investors may view the drugmaker’s post-pandemic transition in 2026: steady underlying growth ambitions, but a near-term financial “air pocket” as COVID-19 revenue continues to shrink and several products face patent and exclusivity headwinds. On December 16, 2025, Pfizer issued its full-year 2026 guidance, projecting revenue of $59.5 billion to $62.5 billion and adjusted EPS of $2.80 to $3.00—both ranges that came in below Wall Street expectations cited by major financial outlets covering the update. Business Wire+2Reuters+2
16 December 2025
···
Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb Company is back in the spotlight on December 16, 2025, with the stock trading around $54.29, up roughly 3.6% on the session as optimism builds around Wall Street upgrades, a newly announced dividend increase, and a steady drumbeat of pipeline and regulatory updates heading into 2026. Smartkarma While BMY has spent much of the past year wrestling with familiar big-pharma headwinds—generic erosion in legacy products and a looming “patent cliff” narrative—the last several weeks have looked more like a sentiment reset than a victory lap. One analysis notes a ~16% move over the last 30 days alongside renewed investor focus on late-stage pipeline and strategic deals. Simply Wall St
16 December 2025
···
Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks

Pfizer Stock (PFE) Today, Dec. 16, 2025: 2026 Guidance Call Looms as Analysts Weigh Dividend, Deal Flow, and Policy Risks

Pfizer Inc. heads into Tuesday, December 16, 2025 with a familiar “big pharma” cocktail of catalysts: an imminent guidance event, a high dividend yield, fresh dealmaking in hot therapeutic areas, and a regulatory backdrop that can flip sentiment faster than a lab centrifuge. Shares closed Monday at $26.43, up 2.24%, extending a four-session winning streak, according to MarketWatch. MarketWatch On the data side, Pfizer’s own calendar is the center of gravity: the company is scheduled to host an 8:00 a.m. EST analyst call today to provide full-year 2026 financial guidance. Pfizer+1
16 December 2025
···
1 … 24 25 26 27 28 … 44

Stock Market Today

  • Mettler-Toledo (MTD) Revenue Beats in Mixed Quarter, Research Tools Stocks Up 20% Since Q1
    July 4, 2026, 1:27 AM EDT. The Research Tools & Consumables group reported Q1 revenue up 1.3% over analyst estimates, serving customers in academia, biotech, and pharma. Mettler-Toledo (NYSE:MTD) booked $947.1 million in sales, up 7.2% from last year and just ahead of forecasts. EPS was less clear, and the stock hovered around $1,308 after the update. Sector shares, on average, climbed 20.8% post-earnings as demand stayed hot for lab tools tied to synthetic biology and personalized medicine. Patchy research funding and supply chain hiccups remain risks. Waters Corporation (NYSE:WAT) was the top mover, with strong Q1 gains from its analytical instruments and consumables business.
Go toTop